Cargando…

Uroplakin IIIa Is a Marker in Bladder Cancer but Seems Not to Reflect Chemical Carcinogenesis

BACKGROUND: Uroplakins are glycoproteins investigated as potential markers of urothelial carcinoma. However, their role in chemical carcinogenesis is uncertain. In this study the diagnostic value of plasma and urine uroplakin IIIa (UPIIIa) levels in bladder cancer (BC) was investigated, particularly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szymańska, B., Matuszewski, M., Dembowski, J., Zdrojowy, R., Długosz, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057425/ https://www.ncbi.nlm.nih.gov/pubmed/30069482 http://dx.doi.org/10.1155/2018/8315410

Ejemplares similares

Uroplakins and their potential applications in urology
por: Matuszewski, Michal Andrzej, et al.
Publicado: (2016)

Preliminary Evaluation of the Diagnostic Usefulness of Uroplakin 2 with an Assessment of the Antioxidant Potential of Patients with Bladder Cancer
por: Matuszewski, M., et al.
Publicado: (2018)

Initial Evaluation of Uroplakins UPIIIa and UPII in Selected Benign Urological Diseases
por: Szymańska, Beata, et al.
Publicado: (2021)

Glycosylation of uroplakins. Implications for bladder physiopathology
por: Kątnik-Prastowska, Iwona, et al.
Publicado: (2014)

Membrane microdomain-associated uroplakin IIIa contributes to Src-dependent mechanisms of anti-apoptotic proliferation in human bladder carcinoma cells
por: Kihira, Shigeru, et al.
Publicado: (2012)

Low molecular weight proteins and enzymes in the urine of patients with bladder cancer – a pilot study
por: Marchewka, Zofia, et al.
Publicado: (2018)

The Diagnostic Value of Nuclear Matrix Proteins in Bladder Cancer in the Aspect of Environmental Risk from Carcinogens
por: Szymańska, Beata, et al.
Publicado: (2017)

Uroplakin IIIb, a urothelial differentiation marker, dimerizes with uroplakin Ib as an early step of urothelial plaque assembly
por: Deng, Fang-Ming, et al.
Publicado: (2002)

The Dependence between Urinary Levels of Angiogenesis Factors, 8-Iso-prostaglandin F2α, ɣ-Synuclein, and Interleukin-13 in Patients with Bladder Cancer: A Pilot Study
por: Szymańska, Beata, et al.
Publicado: (2020)

Bacteria-Induced Uroplakin Signaling Mediates Bladder Response to Infection
por: Thumbikat, Praveen, et al.
Publicado: (2009)

Expressions of Uroplakins in the Mouse Urinary Bladder with Cyclophosphamide-Induced Cystitis
por: Choi, Seong Hoo, et al.
Publicado: (2009)

Generation of divergent uroplakin tetraspanins and their partners during vertebrate evolution: identification of novel uroplakins
por: DeSalle, Rob, et al.
Publicado: (2014)

Uroplakins in the Lower Urinary Tract
por: Lee, Gilho
Publicado: (2011)

High Expression of Human Uroplakin Ia in Urinary Bladder Transitional Cell Carcinoma
por: Kageyama, Susumu, et al.
Publicado: (2002)

Expression of Uroplakin Ib and Uroplakin III Genes in Tissues and Peripheral Blood of Patients with Transitional Cell Carcinoma
por: Yuasa, Takeshi, et al.
Publicado: (1998)

Uroplakin Peptide-Specific Autoimmunity Initiates Interstitial Cystitis/Painful Bladder Syndrome in Mice
por: Izgi, Kenan, et al.
Publicado: (2013)

Changes in uroplakin expression in the urothelium of patients with ulcerative interstitial cystitis/bladder pain syndrome
por: Cho, Kang Jun, et al.
Publicado: (2020)

The role of TSG-6 and uroplakin III in bladder pain syndrome/ interstitial cystitis in rats and humans
por: Lv, Yi-Song, et al.
Publicado: (2017)

Management of bladder neck leiomyoma during pregnancy
por: Tupikowski, Krzysztof, et al.
Publicado: (2011)

Attachment of Cancer Urothelial Cells to the Bladder Epithelium Occurs on Uroplakin-Negative Cells and Is Mediated by Desmosomal and Not by Classical Cadherins
por: Jerman, Urška Dragin, et al.
Publicado: (2021)

Comparison of Antibodies to Detect Uroplakin in Urothelial Carcinomas
por: Kristoffersen, Heidi L., et al.
Publicado: (2022)

The blackboard in the background seems to reflect an ongoing fellow selection
por: CERN PhotoLab
Publicado: (1975)

Long Noncoding RNA Expression Profiling Reveals Upregulation of Uroplakin 1A and Uroplakin 1A Antisense RNA 1 under Hypoxic Conditions in Lung Cancer Cells
por: Byun, Yuree, et al.
Publicado: (2020)

Patient comfort during flexible and rigid cystourethroscopy
por: Krajewski, Wojciech, et al.
Publicado: (2016)

Uroplakins Do Not Restrict CO(2) Transport through Urothelium
por: Zocher, Florian, et al.
Publicado: (2012)

Repeated BCG treatment of mouse bladder selectively stimulates small GTPases and HLA antigens and inhibits single-spanning uroplakins
por: Saban, Marcia R, et al.
Publicado: (2007)

Does restaging transurethral resection of bladder tumour influence outcomes in patients treated with BCG immunotherapy? 491 cases in 20 years’ experience
por: Krajewski, Wojciech, et al.
Publicado: (2018)

Vitamin D and urological cancers
por: Krajewski, Wojciech, et al.
Publicado: (2016)

Heterogeneity of uroplakin localization in human normal urothelium, papilloma and papillary carcinoma
por: Zupancic, Dasa, et al.
Publicado: (2013)

Urological complications after renal transplantation – a single centre experience
por: Krajewski, Wojciech, et al.
Publicado: (2016)

Salvage local therapy for radiation-recurrent prostate cancer – where are we?
por: Zdrojowy, Romuald, et al.
Publicado: (2016)

Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary tract diseases
por: Kong, Xiang-Tian, et al.
Publicado: (2004)

Reflections on a virtual fellowship interview trail: Not as great as it may seem
por: Childers, Christopher P.
Publicado: (2021)

Chemopreventive Efficacy of Thymoquinone in Chemically Induced Urinary Bladder Carcinogenesis in Rat
por: Hamaamin, Karmand Salih, et al.
Publicado: (2022)

Uroplakins Ia and Ib, two major differentiation products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins
Publicado: (1994)

Multistage carcinogenesis in the urinary bladder.
por: Cohen, S M, et al.
Publicado: (1983)

Reduced Expression of Uroplakin 1A Is Associated with the Poor Prognosis of Gastric Adenocarcinoma Patients
por: Zheng, Yan, et al.
Publicado: (2014)

Ablation of Uroplakin III Gene Results in Small Urothelial Plaques, Urothelial Leakage, and Vesicoureteral Reflux
por: Hu, Ping, et al.
Publicado: (2000)

Chemical carcinogenesis.
por: Burrows, T. W.
Publicado: (1969)

Treatment with low-energy shock wave alleviates pain in an animal model of uroplakin 3A-induced autoimmune interstitial cystitis/painful bladder syndrome
por: Li, Huixi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f8od0orj0120o3tckbmck59jtj